doi:10.16150/j.1671-2870.2019.06.019

Abstract

CLC Number:

R692

Figures/Tables 1

References 48

[1]	Watts RA, Mahr A, Mohammad AJ, et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody(ANCA)-associated vasculitis[J]. Nephrol Dial Transplant, 2015, 30(Suppl 1):i14-i22.
[2]	Chen YX, Yu HJ, Zhang W, et al. Analyzing fatal cases of Chinese patients with primary antineutrophil cytoplasmic antibodies-associated renal vasculitis: a 10-year retrospective study[J]. Kidney Blood Press Res. 2008; 31(5):343-349. doi: 10.1159/000165117 URL
[3]	Itabashi M, Takei T, Yabuki Y, et al. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan[J]. Nephron Clin Pract, 2010, 115(1):c21-c27.
[4]	Guillevin L, Cordier JF, Lhote F, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wege-ner's granulomatosis[J]. Arthritis Rheum, 1997, 40(12):2187-2198. doi: 10.1002/art.1780401213 URL
[5]	Kronbichler A, Jayne DR, Mayer G. Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis[J]. Eur J Clin Invest, 2015, 45(3):346-368. doi: 10.1111/eci.12410 pmid: 25627555
[6]	Sada KE, Yamamura M, Harigai M, et al. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study[J]. Arthritis Res Ther, 2015, 17:305. doi: 10.1186/s13075-015-0815-y URL
[7]	Goupil R, Brachemi S, Nadeau-Fredette AC, et al. Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis[J]. Clin J Am Soc Nephrol, 2013, 8(3):416-423. doi: 10.2215/CJN.07300712 URL
[8]	Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients[J]. Rheumatology (Oxford), 2005, 44(4):495-501. doi: 10.1093/rheumatology/keh522 URL
[9]	Guerry MJ, Brogan P, Bruce IN, et al. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis[J]. Rheumatology (Oxford), 2012, 51(4):634-643. doi: 10.1093/rheumatology/ker150 URL
[10]	Charlier C, Henegar C, Launay O, et al. Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients[J]. Ann Rheum Dis, 2009, 68(5):658-663. doi: 10.1136/ard.2008.088302 pmid: 18504289
[11]	Charles P, Néel A, Tieulié N, et al. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients[J]. Rheumatology (Oxford), 2014, 53(3):532-539. doi: 10.1093/rheumatology/ket381 pmid: 24282319
[12]	Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2016, 75(9):1583-1594. doi: 10.1136/annrheumdis-2016-209133 pmid: 27338776
[13]	Kronbichler A, Kerschbaum J, Gopaluni S, et al. Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis[J]. Ann Rheum Dis, 2018, 77(10):1440-1447. doi: 10.1136/annrheumdis-2017-212861 pmid: 29950327
[14]	Cartin-Ceba R, Golbin JM, Keogh KA, et al. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis(Wegener's): ten-year experience at a single center[J]. Arthritis Rheum, 2012, 64(11):3770-3778. doi: 10.1002/art.34584 URL
[15]	Pendergraft WF 3rd, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3[J]. Nat Med, 2004, 10(1):72-79. doi: 10.1038/nm968 pmid: 14661018
[16]	Kain R, Exner M, Brandes R, et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis[J]. Nat Med, 2008, 14(10):1088-1096. doi: 10.1038/nm.1874 URL
[17]	Roth AJ, Brown MC, Smith RN, et al. Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis[J]. J Am Soc Nephrol, 2012, 23(3):545-555. doi: 10.1681/ASN.2011030273 URL
[18]	Peschel A, Basu N, Benharkou A, et al. Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN[J]. J Am Soc Nephrol, 2014, 25(3):455-463. doi: 10.1681/ASN.2013030320 pmid: 24203998
[19]	Takeuchi S, Kimura S, Soma Y, et al. Lysosomal-associa-ted membrane protein-2 plays an important role in the pathogenesis of primary cutaneous vasculitis[J]. Rheumatology (Oxford), 2013, 52(9):1592-1598. doi: 10.1093/rheumatology/ket159 pmid: 23704322
[20]	Zielinski CE, Mele F, Aschenbrenner D, et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β[J]. Nature, 2012, 484(7395):514-518. doi: 10.1038/nature10957 URL
[21]	Dong X, Bachman LA, Miller MN, et al. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction[J]. Kidney Int, 2008, 74(10):1294-1309. doi: 10.1038/ki.2008.394 URL
[22]	Paust HJ, Turner JE, Steinmetz OM, et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis[J]. J Am Soc Nephrol, 2009, 20(5):969-979. doi: 10.1681/ASN.2008050556 URL
[23]	Wilde B, Thewissen M, Damoiseaux J, et al. Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy[J]. Arthritis Res Ther, 2012, 14(5):R227.
[24]	Free ME, Bunch DO, McGregor JA, et al. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population[J]. Arthritis Rheum, 2013, 65(7):1922-1933. doi: 10.1002/art.37959 URL
[25]	Velden J, Paust HJ, Hoxha E, et al. Renal IL-17 expression in human ANCA-associated glomerulonephritis[J]. Am J Physiol Renal Physiol, 2012, 302(12):F1663-F1673.
[26]	Krebs CF, Paust HJ, Krohn S, et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney[J]. Immunity, 2016, 45(5):1078-1092. doi: 10.1016/j.immuni.2016.10.020 URL
[27]	Savage CO, Gaskin G, Pusey CD, et al. Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity[J]. Adv Exp Med Biol, 1993, 336:121-123. pmid: 8296599
[28]	Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease[J]. Nat Rev Rheumatol, 2014, 10(8):463-473. doi: 10.1038/nrrheum.2014.103 pmid: 25003769
[29]	Huang YM, Wang H, Wang C, et al. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps[J]. Arthritis Rheumatol, 2015, 67(10):2780-2790. doi: 10.1002/art.39239 URL
[30]	Kantari C, Pederzoli-Ribeil M, Amir-Moazami O, et al. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interfere-nce with macrophage phagocytosis[J]. Blood, 2007, 110(12):4086-4095.
[31]	Millet A, Martin KR, Bonnefoy F, et al. Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis[J]. J Clin Invest, 2015, 125(11):4107-4121. doi: 10.1172/JCI78182 URL
[32]	Kanehisa M, Goto S, Sato Y, et al. KEGG for integration and interpretation of large-scale molecular data sets[J]. Nucleic Acids Res, 2012,40(Database issue):D109-D114.
[33]	Kerstein A, Schüler S, Cabral-Marques O, et al. Environmental factor and inflammation-driven alteration of the total peripheral T-cell compartment in granulomatosis with polyangiitis[J]. J Autoimmun, 2017, 78:79-91. doi: S0896-8411(16)30186-X pmid: 28040323
[34]	Laudien M, Gadola SD, Podschun R, et al. Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic Rhinosinusitis with nasal polyps[J]. Clin Exp Rheumatol, 2010, 28(1 Suppl 57):51-55. pmid: 20412703
[35]	Addy C, Doran G, Jones AL, et al. Microscopic polyangii-tis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report[J]. BMC Pulm Med, 2018, 18(1):170. doi: 10.1186/s12890-018-0732-3 pmid: 30453935
[36]	Iijima Y, Kobayashi Y, Uchida Y, et al. A case report of granulomatous polyangiitis complicated by tuberculous lymphadenitis[J]. Medicine (Baltimore), 2018, 97(43):e12430.
[37]	Fukusumi M, Miyazaki K, Shibata M, et al. A case of Wegener granulomatosis after treatment for non-tuberculous mycobacteriosis[J]. Nihon Kokyuki Gakkai Zasshi, 2011, 49(1):37-43.
[38]	Yamaguchi M, Yoshioka T, Yamakawa T, et al. Anti-neutrophil cytoplasmic antibody-associated vasculitis associated with infectious mononucleosis due to primary Epstein-Barr virus infection: report of three cases[J]. Clin Kidney J, 2014, 7(1):45-48. doi: 10.1093/ckj/sft140 pmid: 25859349
[39]	Meyer MF, Hellmich B, Kotterba S, et al. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?[J]. Rheumatol Int, 2000, 20(1):35-38. pmid: 11149660
[40]	Lidar M, Lipschitz N, Langevitz P, et al. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200[J]. Ann N Y Acad Sci, 2009, 1173:649-657. doi: 10.1111/j.1749-6632.2009.04641.x URL
[41]	Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease[J]. Nat Rev Immunol, 2006, 6(11):823-835. doi: 10.1038/nri1957 pmid: 17063184
[42]	Uezono S, Sato Y, Hara S, et al. Outcome of ANCA-associated primary renal vasculitis in Miyazaki Prefecture[J]. Intern Med, 2007, 46(12):815-822. doi: 10.2169/internalmedicine.46.6371 URL
[43]	Matsumoto Y, Sada KE, Otsuka F, et al. Evaluation of weekly-reduction regimen of glucocorticoids in combination with cyclophosphamide for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis in Japanese patients[J]. Rheumatol Int, 2012, 32(10):2999-3005. doi: 10.1007/s00296-011-2136-z URL
[44]	Godeau B, Mainardi JL, Roudot-Thoraval F, et al. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis[J]. Ann Rheum Dis, 1995, 54(12):991-994. doi: 10.1136/ard.54.12.991 pmid: 8546533
[45]	Weidanz F, Day CJ, Hewins P, et al. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis[J]. Am J Kidney Dis, 2007, 50(1):36-46. pmid: 17591523
[46]	Lionaki S, Hogan SL, Jennette CE, et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis[J]. Kidney Int, 2009, 76(6):644-651. doi: 10.1038/ki.2009.218 pmid: 19536079
[47]	Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis[J]. Ann Rheum Dis, 2011, 70(3):488-494. doi: 10.1136/ard.2010.137778 pmid: 21109517
[48]	Bligny D, Mahr A, Toumelin PL, et al. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients[J]. Arthritis Rheum, 2004, 51(1):83-91. doi: 10.1002/art.20082 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 48

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	HAO Xu, WANG Weiming. Fabry disease presenting with renal disease as the main manifestation diagnosed by renal biopsy: a case report [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 527-529.
[2]	SHI Xia, MA Xin, WANG Zhenyan, ZHANG Hui, LIU Shaojun. Analysis on the clinicopathological characteristics and follow-up of 32 patients with human immunodeficiency virus infection and chronic kidney diseases [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 437-443.
[3]	HUANG Juan, ZHU Xiaolei, LI Xiao, CHEN Kemin, YAN Fuhua, XU Xueqin. Study on blood oxygen level-dependent magnetic resonance imaging for the assessment of early renal hypoxia in chronic kidney disease [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 385-389.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 245-250.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 125-129.
[6]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 213-215.
[7]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(06): 613-617.
[8]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 229-231.
[9]	WANG Yuanyuan, FAN Qiuling. Clinical value of serum procalcitonin in patients of chronic kidney disease with bacterial infection [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 353-359.
[10]	WU Lin, ZHENG Ge, TAO Ting. Angiotensin-converting enzyme gene insertion/deletion polymorphism and decline of renal function in elderly [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 204-208.
[11]	JIAO Jieru, LI Yanran, CHEN Xiaonong, LIN Qing. Change and significance of clinical indices on treatment with tacrolimus combined with piperazine ferulate for primary nephrotic syndrome in elderly [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 104-106.
[12]	WANG Yimei, TENG Jie, SHEN Bo, XU Jiarui, JIANG Wuhua, YU Jiawei, HU Jiachang, DING Xiaoqiang. Real-time electronic alert system improving the detection of acute kidney injury [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 596-600.
[13]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(04): 347-352.
[14]	LI Huilin, WU Ping, LIU Shuang, JIANG Gengru. Soluble Klotho attenuates high glucose-induced renal fibrosis through inhibiting STAT3 pathway [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(04): 371-376.
[15]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(04): 353-357.